Anita Garlind

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study

Yvonne Freund‐Levi, Maria Eriksdotter, Tommy Cederholm et al. · Archives of Neurology · 2006 · 741 citations

Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms

Yvonne Freund‐Levi, Hans Basun, Tommy Cederholm et al. · International Journal of Geriatric Psychiatry · 2007 · 184 citations

Effects of docosahexaenoic acid–rich n−3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study

Inger Vedin, Tommy Cederholm, Yvonne Freund‐Levi et al. · American Journal of Clinical Nutrition · 2008 · 171 citations · Full text

Inflammation, Allergy, Cytokine Release +7

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

Taher Darreh‐Shori, Ove Almkvist, Zhenpeng Guan et al. · Neurology · 2002 · 155 citations

The Cerebrocortical Areas in Normal Brain Aging and in Alzheimer's Disease: Noticeable Differences in the Lipid Peroxidation Level and in Antioxidant Defense

Ello Karelson, Nenad Bogdanović, Anita Garlind et al. · Neurochemical Research · 2001 · 115 citations